The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
“In 2025, expect AI, fueled by new GenAI-enabled capabilities, to chip away at gains in efficiency, accuracy, and speed ...
24/7 Wall St. on MSN4h
Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape. - Issue Date: ...
BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...
HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical ("Sen-Jam"), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI ...
With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to ...
Scaling personalized therapies brings unique logistical challenges. Unlike mass-market drugs, these treatments require highly specific materials, stringent cold chain logistics and real-time ...
The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback